Fund Management At Engine No. 1 LLC Dexcom Inc Transaction History

Fund Management At Engine No. 1 LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $43,460 - $69,654	505 Added 10.01%	5,550 $517,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $40,601 - $47,283	361 Added 7.71%	5,045 $648,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $44,824 - $52,978	431 Added 10.13%	4,684 $544,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $40,790 - $58,881	480 Added 12.72%	4,253 $481,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $14,353 - $17,705	-188 Reduced 4.75%	3,773 $304,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $213,488 - $417,274	3,140 Added 382.46%	3,961 $295,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $77,239 - $106,894	821 New	821 $420,000

1,035

353M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.